172 related articles for article (PubMed ID: 36016287)
1. Results of a European-Wide External Quality Assessment (EQA) Scheme for Serological Detection of Anti-SARS-CoV-2 (CoVimm)-Pitfalls of Routine Application.
Kittel M; Eichner R; Aida S; Bode A; Ast V; Kessler A; Neumaier M; Wölfel R; Haselmann V
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016287
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
Ast V; Costina V; Eichner R; Bode A; Aida S; Gerhards C; Thiaucourt M; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M; Haselmann V
J Clin Microbiol; 2021 Aug; 59(9):e0055921. PubMed ID: 34190575
[TBL] [Abstract][Full Text] [Related]
3. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
[TBL] [Abstract][Full Text] [Related]
4. Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme.
Sciacovelli L; Padoan A; Secchiero S; Plebani M
Clin Chem Lab Med; 2021 Oct; 59(11):1878-1884. PubMed ID: 34348424
[TBL] [Abstract][Full Text] [Related]
5. External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021.
Mögling R; Colavita F; Reimerink J; Melidou A; Leitmeyer K; Keramarou M; Lapa D; Francalancia M; Murk JL; Vossen A; Carletti F; Hogema B; Meijer A; Deprez L; di Caro A; Castilletti C; Reusken CB
Euro Surveill; 2022 Oct; 27(42):. PubMed ID: 36268736
[TBL] [Abstract][Full Text] [Related]
6. First Results of an External Quality Assessment (EQA) Scheme for Molecular, Serological and Antigenic Diagnostic Test for SARS-CoV-2 Detection in Lombardy Region (Northern Italy), 2020-2022.
Pasotti F; Pellegrinelli L; Liga G; Rizzetto M; Azzarà G; Da Molin S; Lungu OL; Greco S; Galli C; Bubba L; Pariani E; Corradin M; Cereda D; Buoro S
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741293
[TBL] [Abstract][Full Text] [Related]
7. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
[TBL] [Abstract][Full Text] [Related]
8. Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.
Infantino M; Manfredi M; Grossi V; Lari B; Fabbri S; Benucci M; Fortini A; Damiani A; Mobilia EM; Panciroli M; Pancani S; Pesce G
J Med Virol; 2021 Mar; 93(3):1436-1442. PubMed ID: 32790181
[TBL] [Abstract][Full Text] [Related]
9. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
[TBL] [Abstract][Full Text] [Related]
10. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
[TBL] [Abstract][Full Text] [Related]
11. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
12. Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021.
Mögling R; Reimerink J; Stanoeva KR; Keramarou M; Guiomar R; Costa I; Haveri A; Holzer B; Korukluoğlu G; Nguyen T; Pakarna G; Pancer K; Trilar KP; Protic J; Stojanović M; De Santis R; Lista F; Vremera T; Leustean M; Pistol A; Zelena H; Reusken C; Broberg EK
J Virol Methods; 2023 Dec; 322():114825. PubMed ID: 37778539
[TBL] [Abstract][Full Text] [Related]
13. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
[TBL] [Abstract][Full Text] [Related]
14. Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests.
Maine GN; Krishnan SM; Walewski K; Trueman J; Sykes E; Sun Q
J Immunol Methods; 2022 Apr; 503():113243. PubMed ID: 35181288
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.
Huber T; Steininger P; Irrgang P; Korn K; Tenbusch M; Diesch K; Achenbach S; Kremer AE; Werblow M; Vetter M; Bogdan C; Held J
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1983-1997. PubMed ID: 34109500
[TBL] [Abstract][Full Text] [Related]
16. Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera.
Deschermeier C; Ehmen C; von Possel R; Murawski C; Rushton B; Amuasi J; Sarpong N; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Oestereich L; Duraffour S; Pahlmann M; Emmerich P
J Clin Microbiol; 2022 Jun; 60(6):e0007522. PubMed ID: 35574677
[TBL] [Abstract][Full Text] [Related]
17. First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences.
Görzer I; Buchta C; Chiba P; Benka B; Camp JV; Holzmann H; Puchhammer-Stöckl E; Aberle SW
J Clin Virol; 2020 Aug; 129():104537. PubMed ID: 32659712
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Analytical Performance of an Automated Serological Test That Identifies S1/S2-Neutralizing IgG in COVID-19 Patients Semiquantitatively.
Bonelli F; Sarasini A; Zierold C; Calleri M; Bonetti A; Vismara C; Blocki FA; Pallavicini L; Chinali A; Campisi D; Percivalle E; DiNapoli AP; Perno CF; Baldanti F
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32580948
[TBL] [Abstract][Full Text] [Related]
19. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
[TBL] [Abstract][Full Text] [Related]
20. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study.
Buchta C; Aberle SW; Allerberger F; Benka B; Görzer I; Griesmacher A; Hübl W; Huf W; Kapiotis S; Müller MM; Neuwirth E; Puchhammer-Stöckl E; Weseslindtner L; Camp JV
Lancet Microbe; 2023 Dec; 4(12):e1015-e1023. PubMed ID: 37979591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
